CAD1.69
1.74% yesterday
Toronto, Jun 27, 10:00 pm CET
ISIN
CA1380351009
Symbol
WEED

Canopy Growth Corporation Stock price

CAD1.69
-0.66 28.09% 1M
-2.33 57.96% 6M
-2.25 57.11% YTD
-7.47 81.55% 1Y
-47.21 96.54% 3Y
-221.81 99.24% 5Y
-18.01 91.42% 10Y
+1.54 1,026.67% 20Y
Toronto, Closing price Fri, Jun 27 2025
-0.03 1.74%
ISIN
CA1380351009
Symbol
WEED

Key metrics

Basic
Market capitalization
CAD357.2m
Enterprise Value
CAD551.0m
Net debt
CAD193.8m
Cash
CAD131.5m
Shares outstanding
183.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.33 | 1.19
EV/Sales
2.05 | 1.83
EV/FCF
negative
P/B
0.64
Financial Health
Equity Ratio
53.09%
Return on Equity
-122.76%
ROCE
-10.19%
ROIC
-11.30%
Debt/Equity
0.67
Financials (TTM | estimate)
Revenue
CAD269.0m | CAD301.3m
EBITDA
CAD-59.7m | CAD4.2m
EBIT
CAD-83.9m
Net Income
CAD-598.1m | CAD-109.3m
Free Cash Flow
CAD-177.0m
Growth (TTM | estimate)
Revenue
-9.49% | 11.99%
EBITDA
55.61% | 107.09%
EBIT
48.52%
Net Income
8.99% | 81.73%
Free Cash Flow
38.09%
Margin (TTM | estimate)
Gross
30.30%
EBITDA
-22.20% | 1.41%
EBIT
-31.20%
Net
-222.35% | -36.26%
Free Cash Flow
-65.81%
More
EPS
CAD-3.89
FCF per Share
CAD-0.96
Short interest
4.43%
Employees
1.03k
Rev per Employee
CAD260.00k
Show more

Is Canopy Growth Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Canopy Growth Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Canopy Growth Corporation forecast:

1x Buy
7%
5x Hold
33%
9x Sell
60%

Analyst Opinions

15 Analysts have issued a Canopy Growth Corporation forecast:

Buy
7%
Hold
33%
Sell
60%

Financial data from Canopy Growth Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
269 269
9% 9%
100%
- Direct Costs 187 187
13% 13%
70%
82 82
1% 1%
30%
- Selling and Administrative Expenses 141 141
34% 34%
53%
- Research and Development Expense - -
-
-
-60 -60
56% 56%
-22%
- Depreciation and Amortization 24 24
15% 15%
9%
EBIT (Operating Income) EBIT -84 -84
49% 49%
-31%
Net Profit -598 -598
9% 9%
-222%

In millions CAD.

Don't miss a Thing! We will send you all news about Canopy Growth Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Head office Canada
CEO Luc Mongeau
Employees 1,029
Founded 2009
Website www.canopygrowth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today